Xenética en Cancro e Enfermidades Raras
Hospital Universitario Puerta del Mar
Cádiz, EspañaPublications in collaboration with researchers from Hospital Universitario Puerta del Mar (8)
2020
-
High-dose neoadjuvant chemoradiotherapy versus chemotherapy alone followed by surgery in potentially-resectable stage IIIA-N2 NSCLC. A multi-institutional retrospective study by the Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society)
Reports of Practical Oncology and Radiotherapy, Vol. 25, Núm. 3, pp. 447-455
-
Novel CYP4F22 mutations associated with autosomal recessive congenital ichthyosis (ARCI). Study of the CYP4F22 c.1303C>T founder mutation
PLoS ONE, Vol. 15, Núm. 2
2019
-
Management of oligometastatic non-small cell lung cancer patients: Current controversies and future directions
WORLD JOURNAL OF CLINICAL ONCOLOGY, Vol. 10, Núm. 10, pp. 318-339
-
Prognostic factors in neoadjuvant treatment followed by surgery in stage IIIA-N2 non-small cell lung cancer: a multi-institutional study by the Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society)
Clinical and Translational Oncology, Vol. 21, Núm. 6, pp. 735-744
2018
2017
-
Targeted therapy combined with radiotherapy in non-small-cell lung cancer: a review of the Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society)
Clinical and Translational Oncology, Vol. 19, Núm. 1, pp. 31-43
2016
2010
-
The genomics serving pediatrics in the investigation of the multifactorial disease
Acta Pediatrica Espanola, Vol. 68, Núm. 2, pp. 55-60